Screening for Pathogenic Genetic Variants of APOA1 and ABCG1 Genes Associated with Dyslipidemia in Type 2 Diabetic Patients
Screening for Pathogenic Genetic Variants of APOA1 and ABCG1 Genes Associated with Dyslipidemia in Type 2 Diabetic Patients
Asifa Majeed*, Amir Rashid, Palvasha Waheed, Asma Faryal, Aden Razaq and Ayesha Maryam
Molecular analysis of ABCG1 gene: (a) L: DNA ladder; Lane 1-7 DNA samples. (b) L: DNA ladder; Lane 1-3 PCR amplification in samples. (c) Sanger sequencing electro-chromatogram of diabetic dyslipidemia sample.
Molecular analysis of APOA1 gene: (a) L: DNA Ladder; Lane 1-5 PCR amplification of exon 3. (b) Sanger sequencing electro-chromatogram of exon 3 in diabetic dyslipidemia samples. (c) L: DNA ladder; Lane 1-5 PCR amplification of exon 2. (d) Sanger sequencing electro-chromatogram of exon 2 in diabetic dyslipidemia samples.